Carisma Therapeutics Inc. today announced that the company will present at two healthcare industry conferences and one investor conference in the fourth quarter of 2022.
| PHILADELPHIA, Oct. 26, 2022 /PRNewswire/ -- Carisma Therapeutics Inc. a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present at two healthcare industry conferences and one investor conference in the fourth quarter of 2022.
Recent Conferences: Upcoming Conferences: ESMO Immuno-Oncology Congress 2022 About Carisma Therapeutics Carisma Therapeutics Inc. is a biopharmaceutical company dedicated to developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. Carisma is headquartered in Philadelphia, PA. For more information, please visit www.carismatx.com Media Contact:
SOURCE Carisma Therapeutics Inc. |
View original content to download multimedia:
